Navigation Links
Savient Provides Update on Pegloticase BLA
Date:2/12/2009

hase 3 trials, there was a 2:2:1 randomization used, meaning that 4 times as many patients were on drug than placebo. However, in the Open Label Extension study virtually all patients were on drug with only 2 going on observation. The panel determined the following:

  • Combined, and as previously reported in October 2008, there were 5 deaths in the pegloticase treatment arms of the Phase 3 trials and Open Label Extension study compared with 3 deaths in the placebo comparator arm of the Phase 3 trials.

  • As of February 6, 2009, there has been only one additional death in the Open Label Extension study and this was of infectious origin.

Next Steps with the FDA

Upon review of these amendments, the FDA determined that the additional information contained in these submissions constituted a major amendment to the pegloticase BLA, which allowed the FDA under the Prescription Drug User Fee Act (PDUFA) regulations to extend the review period. In order to allow the agency time to consider these amendments, the FDA has notified the Company that the pegloticase BLA priority review PDUFA action date has been extended by three months to July 30, 2009. Given the extended action date, the FDA has also notified the Company that the Advisory Committee meeting previously scheduled for March 5, 2009 will be rescheduled. Savient will provide additional details regarding the rescheduling of the Advisory Committee meeting when a specific date and time have been determined.

Commercialization Update

"While we are eager to move the process forward as quickly as possible, the change in schedule does not impact our planning related to commercialization. The Company has always had a commercialization launch plan that parallels the FDA review process and that will be adjusted to meet the new PDUFA d
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. USAID Provides Malaria Assistance to Zimbabwe
3. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
4. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
5. American Dairy Provides Business Update
6. Alfacell Provides ONCONASE(R) NDA Submission Update
7. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
8. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
9. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... its offering of $80,000,000 aggregate principal amount of 5.25% ... a private offering within the United States ... institutional buyers pursuant to Rule 144A under the Securities ... has also granted the initial purchasers an option to ...
(Date:11/18/2014)... 2014 Breast cancer will interrupt life ... who get a new diagnosis. The Commission for ... case managers to help those diagnosed with advanced ... physical, emotional and financial decisions that come with ... cost via the Commission,s online knowledge resource, the ...
(Date:11/18/2014)... , Nov. 18, 2014 BioLink ... International Technology Transfer Summit, co-organized by CCCMHPIE ( ... Export of Medicines & Health Products), UBM Live ... January 22nd and 23rd, 2015 at Beijing Yizhuang Biomedical ...   This event will gather ...
Breaking Medicine Technology:Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 3
... historic open letter to the World Health Organization ... Drugs (CoMeD) , and the United Methodist Women are seeking ... vaccines.  Currently, the mercury-based preservative Thimerosal, which is 49% mercury ... much of the world, despite the fact that it is ...
... Texas, March 15, 2012  OxySure® Systems, Inc. (OTCBB: ... emergency oxygen solutions with its "oxygen from powder" ... a Supplier Agreement ("Agreement") with W.W. Grainger, Inc. ... (Logo:  http://photos.prnewswire.com/prnh/20120315/DA71084LOGO ) In terms ...
Cached Medicine Technology:Global Call for Mercury-free Vaccines Issued 2OxySure Systems Announces Supplier Agreement With Grainger 2OxySure Systems Announces Supplier Agreement With Grainger 3
(Date:11/21/2014)... CA (PRWEB) November 21, 2014 ... creating picture-perfect smiles for patients in preparation for the ... to the fronts of teeth, look completely natural, and ... certain situations, veneers are also valued for their ability ... patients and can be used on one or several ...
(Date:11/21/2014)... 2014 (HealthDay News) -- The cost of diabetes care ... recent years, climbing to more than $322 billion annually, ... cost were seen with prediabetes care, which have risen ... percent, the researchers added. In 2012, excess medical ... than $1,000 for every American. That total includes $244 ...
(Date:11/21/2014)... November 21, 2014 Richard Wolfe, ... , will present advanced benefits administration strategies during ... Houston HR Leadership Summit. This Game Changer breakout ... industry to present cutting-edge solutions and best practices ... explain how real-time data exchange between health and ...
(Date:11/21/2014)... Saint Luke’s Mid America Heart ... Failure Gold-Plus Quality Achievement Award for implementing specific ... Association/American College of Cardiology Foundation in their secondary ... With The Guidelines–Heart Failure is a quality improvement ... up-to-date, research-based guidelines with the goal of speeding ...
(Date:11/21/2014)... November 21, 2014 The typical Thanksgiving ... calorie dishes, plenty of gravy and a myriad of ... the best time of year to begin losing weight? ... has uncovered the secret to losing unhealthy, embarrassing and ... holiday recipes. , The insight to Diet Doc’s calorie ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4
... in this group , WEDNESDAY, June 2 (HealthDay News) -- ... of developing prostate cancer than white men, but now a ... likely to develop aggressive forms of the disease. , Researchers ... whites -- whose prostates were removed at the Durham Veterans ...
... ... maker of the life’sDHA™ brand, Martek Biosciences Corporation (NASDAQ: MATK) announced today that Norman ... selected as the recipient of the Alex Leaf Distinguished Scientist Award for 2010. ... Columbia, Md. (Vocus) ...
... ... in the last several years. ,Global Launch Management, a product launch management company, offers ... traditional marketing, the product launch marketing model has been very successful for many 60 ... ...
... say , WEDNESDAY, June 2 (HealthDay News) -- A ... for a kind of brain tumor in children, researchers report. ... 20 percent of childhood brain cancer cases. Treatment, which can ... at five years to 70 percent, but the tumors remain ...
... donations have more than doubled since the institution of grassroots ... published in the May issue of the Journal of ... of minority donors is expected to reach 35 percent, up ... organ transplant in 1954, the shortage of organ donors has ...
... reporting new evidence that capsaicin, the stuff that gives chili ... buildup by triggering certain beneficial protein changes in the body. ... appears in ACS, monthly Journal of Proteome Research . ... obesity is a major public health threat worldwide, linked to ...
Cached Medicine News:Health News:Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of ,Alex Leaf Distinguished Scientist Award 2Health News:Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of ,Alex Leaf Distinguished Scientist Award 3Health News:Traditional Marketing is Dead! GLM Creates a Sales Spike in Under 60 Days Stops Business Failure; Provides Startup Funding 2Health News:Grassroots programs to encourage minority organ donation prove successful 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: